Policy Update: China

2019-09-11T15:43:38-04:00

On 10 July 2018, the China Drug Administration (CFDA) released a new guiding principle to allow companies to use overseas clinical trial data in their applications for new drug approvals

Policy Update: China2019-09-11T15:43:38-04:00

Policy Update: Brazil

2019-09-11T15:46:12-04:00

Introducing a new health technology or drug into Brazil’s healthcare system is a complex and interactive process involving many stakeholders, demanding in-country expertise.

Policy Update: Brazil2019-09-11T15:46:12-04:00